(Q48872159)

16 February 2018

title

alpha-Synuclein implicated in Parkinson's disease catalyses the formation of hydrogen peroxide in vitro (English)

1 reference

16 February 2018

1 reference

1 reference

1 reference

16 February 2018

author name string

Turnbull S

1 reference

16 February 2018

Tabner BJ

1 reference

16 February 2018

El-Agnaf OM

1 reference

16 February 2018

Moore S

1 reference

16 February 2018

Davies Y

1 reference

16 February 2018

publication date

1 May 2001

1 reference

16 February 2018

Free Radical Biology and Medicine

published in

1 reference

16 February 2018

volume

1 reference

16 February 2018

issue

1 reference

16 February 2018

page(s)

1163-1170

1 reference

16 February 2018

Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900513-5

7 January 2021

Identification of two distinct synucleins from human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900513-5

7 January 2021

The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900513-5

7 January 2021

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900513-5

7 January 2021

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900513-5

7 January 2021

Alpha-synuclein in Lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900513-5

7 January 2021

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900513-5

7 January 2021

Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900513-5

7 January 2021

Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of alpha-synuclein protein implicated in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900513-5

7 January 2021

Neuropathology in mice expressing human alpha-synuclein

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900513-5

7 January 2021

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900513-5

7 January 2021

Protein precipitation: a common etiology in neurodegenerative disorders?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900513-5

7 January 2021

Protein misfolding, evolution and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900513-5

7 January 2021

The role of oxidative stress in the toxicity induced by amyloid beta-peptide in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900513-5

7 January 2021

Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900513-5

7 January 2021

Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900513-5

7 January 2021

Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900513-5

7 January 2021

Assembly of A beta amyloid protofibrils: an in vitro model for a possible early event in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900513-5

7 January 2021

The Aβ Peptide of Alzheimer's Disease Directly Produces Hydrogen Peroxide through Metal Ion Reduction†

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900513-5

7 January 2021

Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900513-5

7 January 2021

Induction of neuronal death by α-synuclein

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900513-5

7 January 2021

Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900513-5

7 January 2021

Apolipoprotein E increases the fibrillogenic potential of synthetic peptides derived from Alzheimer's, Gelsolin and AA amyloids

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900513-5

7 January 2021

Hydroxyl radical generation by coal mine dust: possible implication to coal workers' pneumoconiosis (CWP)

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900513-5

7 January 2021

Copper(II)-induced self-oligomerization of alpha-synuclein.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900513-5

7 January 2021

Characterization of Copper Interactions with Alzheimer Amyloid β Peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900513-5

7 January 2021

Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900513-5

7 January 2021

alpha-synuclein promotes mitochondrial deficit and oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900513-5

7 January 2021

Understanding cell death in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900513-5

7 January 2021

A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900513-5

7 January 2021

Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900513-5

7 January 2021

Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900513-5

7 January 2021

Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900513-5

7 January 2021

10.1016/S0891-5849(01)00513-5

Identifiers

DOI

1 reference

16 February 2018

1 reference

16 February 2018